TMTeresa Collazo Mesa

Teresa Collazo Mesa

*This is an algorithmically generated author record based on publicly available information.

Teresa Collazo Mesa has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Caracterización citogenética y molecular de cuatro pacientes con desarrollo sexual diferente

    by Anduriña Barrios-Martínez, Damarys García-Gómez, Enny Morales-Rodríguez, Michel Soriano-Torres, Marilyn Del Sol-González, Teresa Collazo-Mesa, Luis Mendez Rosado

    Las diferencias del desarrollo sexual, comprenden un espectro diverso de condiciones originadas por alteraciones en las etapas del desarrollo fetal relacionadas con el sexo genético, gonadal o fenotípico. Con una prevalencia inferior a 1 caso por cada 2 000 recién nacidos, estas entidades se clasifican como enfermedades raras. El objetivo fue caracterizar citogenéticamente y molecularmente a cuatro pacientes con desarrollo sexual diferente con el fin de establecer correlaciones genotipo-fenotipo. Fueron evaluados cuatro pacientes, debido a los trastornos reproductivos que presentaban. Se realizó cultivo de linfocitos con bandeo GTG, complementado con hibridación in situ fluorescente mediante sondas centroméricas del X y locus específico del gen SRY. También la detección del gen SRY se llevó a cabo mediante reacción en cadena de la polimerasa. Tres pacientes con fenotipo masculino presentaron cariotipo 46,XX y presencia del gen SRY, sugiriendo una translocación del locus SRY al cromosoma X durante la meiosis paterna. Un paciente con fenotipo femenino mostró un cariotipo 46,XY y ausencia del gen SRY. Se observan peculiaridades fenotípicas en los pacientes acordes con el diagnóstico realizado. La integración de técnicas citogenéticas (cariotipo + FISH) y moleculares (detección de SRY) es fundamental para el diagnóstico preciso de estas entidades. Estos hallazgos no solo permiten elucidar mecanismos genéticos subyacentes, sino que también orientan estrategias de asesoramiento genético personalizadas, minimizando la incertidumbre clínica en las familias afectadas.

  • Open Access

    High-resolution dissociation analysis for the molecular diagnosis of cystic fibrosis in Cuba.

    by Teresa Collazo Mesa, Ixchel López Reyes, Mercy Estévez Miere, Alejandro Esperón Álvarez, Fidel Rodríguez Cala

    Cystic fibrosis is a common recessive disease in the Caucasian population. Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene can cause damage to the protein it encodes. Seven mutations are directly analyzed in Cuba, representing 55.5% of the pathogenic allelic variants in cystic fibrosis patients. The high allelic heterogeneity of this gene and its varied phenotypic expression make it vitally important to detect a greater number of genetic variants that cause the disease. With this data, patients can receive better genetic counseling and personalized treatment that would improve their quality of life. It is therefore necessary to search for new variants to complete the diagnosis. The objective of this work was to identify new genetic variants in the CFTR gene and confirm the clinical diagnosis of Cystic Fibrosis. Twenty-one patients clinically diagnosed as cystic fibrosis by the National Medical Genetics Network or identified as positive through the Neonatal Screening Program were analyzed. Eleven real-time polymerase chain reaction assays were performed on the isolated DNA, followed by high-resolution dissociation curve analysis. The amplification of these eleven fragments covered the five exons of the gene with the highest number of described mutations and the adjacent intronic regions. Subsequently, the samples that showed changes in the curve pattern were sequenced. Five mutations were detected: one pathogenic, two of uncertain significance, one benign, and one with conflicting clinical significance. Point genetic variants were identified in four of the five exons analyzed. The real-time polymerase chain reaction – high resolution melting curve technique proved useful for searching for point mutations along the CFTR gene sequence, which, in combination with Sanger sequencing, will allow for the identification of new variants in the Cuban population.

  • Open Access

    Characterisation of exon two of the GJB2 gene in Cubans with autosomal recessive prelingual isolated hearing loss

    by Estela Morales Peralta, Mercedes Arceo Alvarez, Yuledmi Perdomo Chacón, Teresa Collazo Mesa, Katrin Beyer

    INTRODUCTION: Hearing loss is the most common neurological disorder in humans. In its prelingual form, it occurs in one in every 1,000 live births. The most common type is isolated autosomal recessive hearing loss, caused mainly by pathogenic variants of the GJB2 gene. The most common of these in all populations is c.35delG, located in exon two, which encodes this gene. This mutation has been identified in heterozygosity in Cubans with hearing loss. Given its high allelic heterogeneity, Sanger sequencing is recommended to confirm the molecular diagnosis. OBJECTIVE: To characterise exon 2 of the GJB2 gene in a series of Cuban patients with autosomal recessive prelingual isolated hearing loss. MATERIAL AND METHOD: A descriptive, cross-sectional study was conducted. From 379 cases in which molecular study was performed by allele-specific PCR of the pathogenic variant c.35delG, 13 heterozygotes were selected in which deletions D13S1830 and D13S1854 of the GJB6 gene had previously been ruled out. Sanger sequencing of exon 2 was performed, for which four specific oligonucleotides were designed to amplify two overlapping fragments to ensure complete analysis of the coding region of the GJB2 gene. Given the characteristics of the c.35delG mutation, two additional primers were included to analyse the start of exon 2. Information on the identified variants was sought on the ClinVar website. The audiometric characteristics of the patients were observed. Throughout the research, the principles of human research ethics were followed. RESULTS The c.427C>T variant was identified in three individuals, while the c.94C>T mutation was found in another, and c.139G>T in a fifth. The patients presented sensorineural hearing loss with severity levels exceeding 61 dB. CONCLUSION: Three pathogenic variants were identified in the coding region of the GJB2 gene, associated with severe to profound hearing loss.

  • Open Access

    Epidemiological and population genetic characterization of fucosidosis in Holguin province, Cuba

    by Víctor Jesús Tamayo Chang, Estela Morales Peralta, Paulina Araceli Lantigua Cruz, Teresa Collazo Mesa, Elayne Esther Santana Hernández, Roberto Lardoeyt Ferrer

    Introduction: Fucosidosis is a rare lysosomal storage disease, of which in Cuba, patients have been reported only in Holguín province.Objective: to characterize the epidemiological and genetic-population behavior of fucosidosis in Holguín province.Method: A case series study was carried out, whose universe and sample included all families with patients with fucosidosis, diagnosed between 1985 and 2023. Birth prevalence, mortality rate, attributable mortality, and consanguinity rate were calculated. Gene and genotypic frequencies were estimated from the prevalence. A Hardy-Weinberg test for the analysis of gene equilibrium at the FUCA 1 locus was applied to the results of the genotypic characterization for the Q427X mutation.Results: 19 patients were diagnosed, belonging to 13 families, which represented a birth prevalence of 3.28 x 105 live births. The case fatality and parental consanguinity rates were 0.84 and 0.53 respectively. The estimated frequencies of the recessive allele and the heterozygous genotype were 0.0057271 and 0.0113887, respectively, so approximately 11,660 people in the population of the Holguín province at the end of 2023 must have been carriers. The existence of gene equilibrium for the FUCA1 locus in the population genotypically characterized for the Q427X mutation suggests that the affected families have remained in the original region, and systematic and stochastic factors that alter gene frequencies, including the existence of gene flow, have not occurred since the apparition of the disease due to a founder effect. The mutation rate of the gene must have remained constant according to the selection coefficient at the locus, corresponding to a lethal disease whose fitness is zero.Conclusions: The prevalence of fucosidosis in Holguín province is one of the highest worldwide and is the result of the combination of the founder effect due to genetic drift of the Q427X mutation, with parental consanguinity and genetic isolation due to socioeconomic causes


  • Open Access

    Germline variants in the Von Hippel-Lindau tumor suppressor gene in Cuban patients

    by Antonio Alejandro Esperón Álvarez, Inés Virginia Noa Hechavarría, Ixchel López Reyes, Teresa Collazo Mesa

    Background: Von Hippel-Lindau (VHL) syndrome is an autosomal dominantly inherited disorder that predisposes to multiple neoplasms. Patients may develop hemangioblastomas of the central nervous system and retina, multiple cysts in the pancreas and kidneys, renal carcinoma, and pheochromocytomas, among other lesions. This disease is caused by germline genetic variants in the VHL gene. The regulation of the alpha subunit of hypoxia-inducible factor-1 is the key tumor suppressor function of the VHL protein. To date, more than seven hundred variants have been reported in VHL gene. This study aimed to investigate the molecular etiology of VHL syndrome in Cuban patients. Results: DNA samples from twenty-two individuals were analyzed by Sanger sequencing or enzymatic restriction. The analysis identified four novel pathogenic variants for the Cuban population: c.463 + 2T > C, C162W, R167W, and S183X, in addition to D121G and R161X, previously described in another work. The diagnosis was confirmed in seven patients with clinical manifestations and family history. Two at-risk family members without clinical signs were positive for presymptomatic diagnosis. Conclusions: The spectrum of germinal point mutations of VHL gene in Cuban patients was updated. The presence of genetic variants was ruled out in eight asymptomatic relatives, which is a psychological relief for these individuals. The results allow for offering other at-risk relatives the presymptomatic diagnosis and the possibility of receiving genetic counseling.

  • Open Access

    Pathogenic variant c.35delG of the GJB2 gene associated with nonsyndromic prelingual deafness

    by Estela Morales Peralta, Mercedes Arceo Alvarez, Yuledmi Perdomo Chacón, Manuel Gómez Martínez, Teresa Collazo Mesa

    Introduction: the pathogenic variant c.35delG of the GJB2 gene is the most frequently observed in all populations, associated with nonsyndromic autosomal recessive prelingual prelingual sensorineural deafness, since 2001 is available in the National Network of Medical Genetics the study of this mutation. Objective: to describe the presence of the pathogenic variant c.35delG of the GJB2 gene associated with nonsyndromic prelingual deafness, with evidence of autosomal recessive inheritance. Methods: a descriptive cross-sectional study was carried out on 379 cases registered with isolated prelingual hearing loss between 2001 and 2023; for the identification of the c.35delG mutation, the polymerase chain reaction technique was used, with enzymatic digestion, and its genotype and frequency were described. Results: the pathogenic variant c.35delG of the GJB2 gene was found in 121 of those studied (31,91 %), 59 in homozygosis and 62 in heterozygosis. The allele frequency found among the positive cases was 0,743. Conclusion: the pathogenic variant c.35delG in individuals with nonsyndromic prelingual deafness of possible autosomal recessive inheritance is found in a high proportion


  • Open Access

    Chromosomal aberrations in patients with suspected Prader Willi syndrome

    by Damarys García Gómez, Alina García García, Araceli Lantigua Cruz, Estela Morales Peralta, Arlay Castelví López, Odalis Molina Gamboa, Enny Morales Rodríguez, Anduriña Barrios Martínez, Teresa Collazo Mesa, Lainet Santos Merencio, et al.

    Introduction: Prader-Willi syndrome, caused by the absence of expression of the paternal 15q11-13 region, is the first imprinting defect disorder described in humans. With an incidence of 1 in 10000-15000, its clinical phenotype characterized by hypotonia, obesity and hypogonadism overlaps with a group of genetically heterogeneous syndromes defined as Prader Willi-like syndrome or Prader Willi like. In this group, deletion 1p36, deletion 2p, deletion 6q, among others, are reported. Objective: to identify chromosomal aberrations in the conventional karyotype of patients with suspected Prader Willi syndrome. Methods: we analyzed the results of conventional karyotyping in lymphocytes, FISH molecular studies and methylation-based polymerase chain reaction of 112 patients referred during the period 2010-2019 for suspected Prader Willi syndrome. Results: Prader Willi syndrome was confirmed in 45,5 % of the patients. Chromosomal aberrations outside the 15q11.13 region were found in 5,3 % of cases including: chromosome 22 ring, trisomy 21 mosaic, 6p admixture, reverse sex and chromosome 21 inversion. Conclusions: In patients with Prader Willi phenotype, clinical suspicion is often not confirmed by molecular studies. Conventional karyotyping may reveal Prader Willi-like syndrome due to aberrations at sites involved in neuroendocrine control outside the 15q11.13 region. In these cases chromosomal diagnosis is essential for more effective prevention strategies as part of genetic counseling for patients and families.

  • Open Access

    A16974C polymorphism of the IL-12 p40 gene in Cuban patients having recovered from COVID-19

    by Estela Morales Peralta, Yaíma Zúñiga Rosales, Teresa Collazo Mesa, Elvia Nelemi Santos González, Yadira Hernández Pérez, María de Los Angeles González Torres, Hilda Roblejo Balbuena, Beatriz Marcheco Teruel

    COVID-19 has had severe consequences worldwide. It has been estimated that the contribution of genetic factors to the disease is about 50%. The A16974C polymorphism of the IL-12 p40 gene has been described as being related to resistance or susceptibility to other infectious diseases; therefore, it is likely that it can also be related to COVID-19. The objective of this study was to describe the relationship between the A16974C polymorphism of the IL12 p40 gene with clinical forms of COVID-19 in Cuban patients. The genotypes of the A16974C polymorphism of gene IL-12 p40 were determined through PCR in 102 persons with a COVID-19 epidemiologic discharge from the hospital. In this research, the CC genotype of this polymorphism was found only in symptomatic cases of this disease; since there are signs of relationship between the A16974C polymorphism of the IL12 p40 gene with clinical forms of COVID-19 in the studied Cuban patients, the variations of this polymorphism may be a predisposing risk factor in the development of COVID-19.

  • Open Access

    Genotype-Phenotype Correlation in Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency in Cuba

    by Tania Mayvel Espinosa Reyes, Teresa Collazo Mesa, Paulina Arasely Lantigua Cruz, Adriana Agramonte Machado, Emma Domínguez Alonso, Henrik Falhammar

    Background. There are several studies that show a good genotype-phenotype correlation in congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD). However, there is well-documented evidence of inconsistency in some cases. Objectives. To determine if there is a correlation between the identified mutations and the clinical manifestations of 21OHD in the Cuban population. Methods. A cross-sectional descriptive study of all patients referred for a molecular diagnosis of 21OHD in Cuba from January 2000 to December 2018. The clinical manifestations of each patient were identified and classified according to the phenotype. The CYP21A2 gene was analyzed for the presence of 5 point mutations involved in the pathogenesis of 21OHD (intron 2, deletion of 8bp, I172N, P30L, and Q318X); correlation was sought between the phenotypic characteristics and the frequencies of point mutations in the patients using the Spearman test. Results. A total of 55 patients underwent direct analysis of the CYP21A2 gene in order to determine the presence of the 5 point mutations. Point mutations were identified in 31 patients, which corresponded to 56. A statistically significant genotype-phenotype correlation was found. Conclusions. The correlation between the detected molecular defect and the clinical expression of 21OHD was reasonable in the Cuban population, which could allow phenotypic predictions to be made from the genotype.


  • Open Access

    A simple, fast and inexpensive method for mutation scanning of CFTR gene

    by Juan Emilio Figueredo Lago, Anny Armas Cayarga, Yaimé Josefina González González, Teresa Collazo Mesa

    Mutation scanning methods in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene may not distinguish between a Cystic Fibrosis (CF) causing mutation and a benign variant. We have developed a simple and fast method for scanning 14 selected CF-causing mutations which have high frequency in Latin America. In a group of 35 samples coming from CF patients previously characterized and using two allele-specific real-time multiplex PCRs targeting wild-type and mutant alleles respectively, we detect the presence of mutations by analyzing the Ct variation. Twenty-five samples without mutations considered non-carrier samples, were also included in this study. High Resolution Melting Analysis (HRMA) was performed to confirm the result of the scanning method and in most cases allowed the genotype determination. The results validate this method for CF diagnosis. A least one CFTR gene mutation was detected in the samples of CF patients, as predicted by their ΔCt values. The ΔCt value also indicated the zygosity of the sample according to the distribution of CFTR gene mutations. In most cases, HRMA allowed the identification of the mutation(s), thereby confirming the efficiency of this scanning strategy. This strategy simplifies the detection of CF, reducing the analysis of 14 CF-causing mutations to two parallel reactions and making the procedure compatible with the analysis of a large number of samples. As the method is fast, inexpensive and highly reliable, it is advisable for scanning CFTR gene mutations in newborns, patients with a clinical suspicion of CF as well as in the preconception carrier screening.